Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible-light synthesis of 1-iodo-3-perfluoroalkyl olefins. Cost-effective, scalable manufacturing for pharmaceutical and agrochemical intermediates with high Z-selectivity.
Patent CN117362140A reveals a photoredox synthesis method for cyclohexyl substituted styrenes. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable visible-light catalysis.
Patent CN119431226A reveals a visible light catalytic method for beta-aryl beta-pyridyl alkyl ketones offering mild conditions and scalable supply chain advantages.
Patent CN112979580B reveals metal-free visible light synthesis for alkylbenzothiazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113717071A reveals a green visible light catalyzed method for acetamide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111205185A introduces a green visible light method for β-trifluoromethyl alcohol using manganese catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN121063999A reveals a green visible light method for methyl arylformate. Discover cost reduction in pharmaceutical intermediates manufacturing and high-purity supply.
Patent CN104803898B reveals a green visible light method for thioethers. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116041220B reveals a green visible light catalytic method for aryl-substituted amides, offering high selectivity and cost-effective manufacturing for pharmaceutical intermediates.
Efficient visible light synthesis method for beta-ketone sulfonyl compounds offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116730915A enables metal-free asymmetric catalysis. Offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Discover a green, metal-free method for synthesizing 2-substituted 3-methylindole derivatives using g-C3N4 photocatalysis, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN113801081A reveals a metal-free visible light method for 2,5-furandicarboxylic acid. Discover cost-effective, scalable bio-based monomer production strategies.
Patent CN117049973A details a green visible light method for aromatic amine functionalization, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Novel photochemical route for benzyl phosphine oxides. High yield up to 81%. Metal-free process ensures cost reduction in API manufacturing and supply chain stability.
Patent CN107857717A reveals visible light catalyzed synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112979580A reveals a metal-free visible light method for alkylbenzothiazoles, offering green synthesis and cost reduction for pharma intermediates.
Patent CN111072720B reveals a metal-free photocatalytic route for phosphono-heterocycles, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN120647657A reveals metal-free visible light synthesis for sulfonylated benzazepine indolones. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN108191651B details a mild, site-specific phenolic ester synthesis using thiocarboxylic acids and visible light photocatalysis, offering significant cost and safety advantages.